Fc Engineered Anti-Human GD2 Antibody, CDC-Enhanced (CAT#: BioBet-C019ZP) Datasheet

GD2

Whole Chimeric Antibody

Fc Engineered Anti-Human GD2 Antibody, CDC-Enhanced (BioBet-C019ZP) is a recombinant monoclonal Whole Chimeric antibody against GD2. This product is a CDC enhanced antibody produced by our proprietary platform.

Severe Eosinophilic Asthma
Severe nasal polyposis
Adult patients with eosinophilic granulomatosis

Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced Dinutuximab. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.